Prophylactic Mastectomy

Surgical Clinics of North America

Volumn 87, Issue 2, 2007, Pages 317-331

  Zakaria, Shaheen ^a   Degnim, Amy C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; FAMILY HISTORY; HUMAN; IMAGING; MASTECTOMY; ONCOGENE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SALPINGOOOPHORECTOMY; SENTINEL LYMPH NODE BIOPSY; STATISTICAL MODEL; SURGICAL TECHNIQUE;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; MASTECTOMY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 34247887567     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.01.009     Document Type: Review

References (79)

1. Feuer E.J., Wun L.M., Boring C.C., et al. The lifetime risk of developing breast cancer. J Natl Cancer Inst 85 11 (1993) 892-897
2. Alexander N.E., Ross J., Sumner W., et al. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11 2 (1996) 92-97
3. Rockhill B., Spiegelman D., Byrne C., et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93 5 (2001) 358-366
4. Antoniou A., Pharoah P.D., Narod S., et al. Average risk of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 5 (2003) 1117-1130
5. Claus E.B., Risch N., and Thompson W.D. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 73 3 (1994) 643-651
6. Foote F.W., and Stewart F.W. Comparative studies of cancerous versus noncancerous breast, I and II. Ann Surg 131 (1945) 197-222
7. Rosen P.P., Groshen S., Kinne D.W., et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 196 5 (1989) 904-910
8. 0 stage I breast carcinoma: a 20-year follow-up study. J Clin Oncol 9 9 (1991) 1650-1661
9. Harris R.E., Lynch H.T., and Guirgis H.A. Familial breast cancer: risk to the contralateral breast. J Natl Cancer Inst 60 5 (1978) 955-960
10. Verhoog L.C., Brekelmans C.T., Seynaeve C., et al. Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 351 9099 (1998) 316-321
11. Verhoog L.C., Brekelmans C.T., Seynaeve C., et al. Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 17 11 (1999) 3396-3402
12. Robson M., Gilewski T., Haas B., et al. BRCA-associated breast cancer in young women. J Clin Oncol 16 5 (1998) 1642-1649
13. Pierce L.J., Levin A.M., Rebbeck T.R., et al. Ten-year multi-institutional results of breast conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 24 (2006) 2437-2443
14. Anderson D.E., and Badzioch M.D. Bilaterality in familial breast cancer patients. Cancer 56 (1985) 2092-2098
15. Lesser M.L., Rosen P.P., and Kinne D.W. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 91 2 (1982) 234-240
16. Storm H.H., and Jensen O.M. Risk of contralateral breast cancer in Denmark, 1943-80. Br J Cancer 54 3 (1986) 483-492
17. Healey E.A., Cook E.F., Oray E.J., et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 11 8 (1993) 1545-1552
18. Broet P., de la Rochefordiere A., Scholl S.M., et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13 7 (1995) 1578-1583
19. Goldflam K., Hunt K.K., Gershenwald J.E., et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 101 9 (2004) 1977-1986
20. Robinson E., Rennert G., Rennert H.S., et al. Survival of first and second primary breast cancer. Cancer 71 1 (1993) 172-176
21. Hartmann L.C., Sellers T.A., Frost M.H., et al. Benign breast disease and the risk of breast cancer. N Engl J Med 353 (2005) 229-237
22. Kerlikowske K., Shepherd J., Creasman J., et al. Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst 97 5 (2005) 368-374
23. Mandelson M.T., Oestreicher N., Porter P.L., et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92 13 (2000) 1081-1087
24. Meijers-Heijboer H., van Geel B., van Putten W.L., et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA 2 mutation. N Engl J Med 345 3 (2001) 159-164
25. Hartmann L.C., Sellers T.A., Schaid D.J., et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93 21 (2001) 1633-1637
26. Rebbeck T.R., Friebel T., Lynch H.T., et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22 6 (2004) 1055-1062
27. Hartmann L.C., Schaid D.J., Woods J.E., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340 2 (1999) 77-84
28. Geiger A.M., Yu O., Herrinton L.J., et al. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Arch Intern Med 165 5 (2005) 516-520
29. Borgen P.I., Hill A.D., Tran K.N., et al. Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 5 7 (1998) 603-606
30. Eldar S., Meguid M.M., and Beatty J.D. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 148 (1984) 692-693
31. Goodnight J.E., Quagliana J.M., and Morton D.L. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 26 (1984) 198-201
32. Holleb A., Montgomery R., and Farrow J.H. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet 121 (1965) 819-822
33. Jameson M.B., Roberts E., Nixon J., et al. Metastatic breast cancer 42 years after bilateral subcutaneous mastectomies. Clin Oncol (R Coll Radiol) 9 (1997) 119-121
34. Willemsen H.W., Kaas R., Peterse J.H., et al. Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. Eur J Surg Oncol 24 (1998) 331-338
35. Ziegler L.D., and Kroll S.S. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol 14 (1991) 451-454
36. Schrag D., Kuntz K.M., Garber J.E., et al. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336 20 (1997) 1465-1471
37. Grann V.R., Jacobson J.S., Thomason D., et al. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol 20 10 (2002) 2520-2529
38. Gabriel S., Woods J., O'Fallono M., et al. Complications leading to surgery after breast implantation. N Engl J Med 336 10 (1997) 677-682
39. Contant C.M., Menke-Pluijmers M.B., Seynaeve C., et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Oncol 28 6 (2002) 627-632
40. Barton M.B., West C.N., Liu I.-L.A., et al. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr 35 (2005) 61-66
41. Zion S.M., Slezak J.M., Sellers T.A., et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 98 10 (2003) 2152-2160
42. Frost M.H., Schaid D.J., Slezak J.M., et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284 (2000) 319-324
43. Stefanek M.E., Helzlsouer K.J., Wilcox P.M., et al. Predictors of satisfaction with bilateral prophylactic mastectomy. Prev Med 24 4 (1995) 412-419
44. Bresser P.J.C., Seynaeve C., Van Gool A.R., et al. Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 117 6 (2006) 1675-1682
45. Metcalfe K.A. Prophylactic bilateral mastectomy for breast cancer prevention. J Womens Health 13 7 (2004) 822-829
46. Metcalfe K.A., Esplen M.J., Goel V., et al. Predictors of quality of life in women with a bilateral prophylactic mastectomy. Breast J 11 1 (2005) 65-69
47. van Sprundel T.C., Schmidt M.K., Rookous M.A., et al. Risk reduction of contralateral breast cancer and survival after contralateral mastectomy in BRCA1 and BRCA2 mutation carriers. Br J Cancer 93 3 (2005) 287-292
48. McDonnell S.K., Schaid D.J., Myers J.L., et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19 19 (2001) 3938-3943
49. Peralta E.A., Ellenhorn J.D.I., Wagman L.D., et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180 6 (2000) 439-445
50. Herrinton L.J., Barlow W.E., Yu O., et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23 19 (2005) 4275-4286
51. Brekelmans C.T., Seynaeve C., Menke-Pluymers M., et al. Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17 3 (2006) 391-400
52. Lee J.S.Y., Grant C.S., Donohue J.H., et al. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery 118 4 (1995) 640-648
53. Babiera G.V., Lowry A.M., Davidson B.S., et al. The role of contralateral prophylactic mastectomy in invasive lobular carcinoma. Breast J 3 1 (1997) 2-6
54. Lostumbo L., Carbine N., Wallace J., et al. Prophylactic mastectomy in the prevention of breast cancer. Cochrane Database Syst Rev 4 (2004) CD002748. pub2. doi: 10.1002/14651858
55. Montgomery L.L., Tran K.N., Heelan M.C., et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6 (1999) 546-552
56. Geiger A.M., West C.N., Nekhlyudov L., et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 24 9 (2006) 1350-1356
57. Frost M.H., Slezak J.M., Tran N.V., et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23 31 (2005) 7849-7856
58. Lynch H.T., Lemon S.J., Durham S.T., et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79 (1997) 2219-2228
59. King M.C., Wieand S., Hale K., et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABBP-P1) Breast Cancer Prevention Trial. JAMA 286 (2001) 2251-2256
60. Loman N., Johansson O., Bendahl P.-O., et al. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA 2 mutations or unknown susceptibility genes. Cancer 83 (1998) 310-319
61. Eisinger F., Jacquemier J., Nogues C., et al. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 85 (1999) 2291-2295
62. Narod S.A., Brunet J., Ghadirian P., et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet 356 (2000) 1876-1881
63. Gronwald J., Tung N., Foulkes W.D., et al. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118 9 (2006) 2281-2284
64. Peshkin B.N., Isaacs C., Finch C., et al. Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. J Clin Oncol 21 (2003) 4322-4328
65. Kauff N.D., Satagopan J.M., Robson M.E., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Eng J Med 346 (2002) 1609-1615
66. Rebbeck T.R., Lynch H.T., Neuhausen S.L., et al. Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Eng J Med 346 (2002) 1616-1622
67. Eisen A., Lubinski J., Klijn J., et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23 30 (2005) 7491-7496
68. Newman L.A., Kuerer H.M., Hunt K.K., et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 5 7 (1998) 620-626
69. Simmons R.M., Fish S.K., Gayle L., et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol 6 7 (1999) 676-681
70. Crowe Jr. J.P., Kim J.A., Yetman R., et al. Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg 139 2 (2004) 148-150
71. Garcia-Etienne C.A., and Borgen P.I. Update on the indications for nipple-sparing mastectomy. J Support Oncol 4 5 (2006) 225-230
72. Bernstein J.L., Thomson W.D., Risch N., et al. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136 8 (1992) 925-936
73. Fisher E.R., Fisher B., Sass R., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer 54 12 (1984) 3002-3011
74. Singletary S.E., Taylor S.H., Guinee V.F., et al. Occurrence and prognosis of contralateral carcinoma of the breast. J Am Coll Surg 178 4 (1994) 390-396
75. Boughey J.C., Khakpour N., Meric-Bernstam F., et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107 7 (2006) 1440-1447
76. MacMahon B., Cole P., Lin T.M., et al. Age at first birth and breast cancer risk. Bulletin of the World Health Organization 43 (1970) 209-221
77. Russo I.H., and Russo J. Hormonal approach to breast cancer prevention. J Cell Biochem Suppl 34 (2000) 1-6
78. Society of Surgical Oncology. Position statement on prophylactic mastectomy. Available at: http://www.surgonc.org/default.aspx?id=179. Accessed October 2, 2006.
79. Nckhlyudov L., Bower M., Herrinton L.J., et al. Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr 35 (2005) 55-60